Revelation Pharma launches PGY1 residency program focused on pharmacy compounding
KENNESAW, Georgia – REVELATION PHARMA, a national network of 503A and 503B compounding pharmacies, is thrilled to announce the launch of its PGY1 residency program for fourth-year pharmacy students.
Offered through Innovation Compounding in Kennesaw, Georgia, the year-long residency will provide critical training and resources for P4 pharmacy students looking to pursue a career in compounding pharmacy.
Compounding is unique as it straddles the origins of the pharmacy profession as well as its future in personalized medicine. Revelation Pharma's PGY1 residency program is the perfect opportunity for pharmacy students who are interested in the core values of pharmacy and who want to focus on patients as individuals.
The residency includes training in sterile and nonsterile compounding, ethical pharmacy compounding, research and development (including patient outcomes research), leadership and management, and compounding advocacy. It includes a $54,000 stipend; health, dental, and vision insurance; paid holidays; and more.
Interested students can find more information and apply for one of the two positions available in 2024 by visiting revelationpharma.com/revelation-group-pgy1. The application deadline is January 16, 2024. Please direct any questions or application materials to Residency Program Director Brandon Sucher at bsucher@revcustomrx.com.
